Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Other Accumulated Expenses (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Other Accumulated Expenses for 7 consecutive years, with $92000.0 as the latest value for Q1 2024.

  • Quarterly Other Accumulated Expenses rose 67.27% to $92000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $92000.0 through Mar 2024, up 67.27% year-over-year, with the annual reading at $24000.0 for FY2023, 71.43% up from the prior year.
  • Other Accumulated Expenses hit $92000.0 in Q1 2024 for Solid Biosciences, up from $24000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $162000.0 in Q3 2023 to a low of $14000.0 in Q4 2022.
  • Historically, Other Accumulated Expenses has averaged $74250.0 across 4 years, with a median of $67000.0 in 2021.
  • Biggest YoY gain for Other Accumulated Expenses was 408.7% in 2023; the steepest drop was 63.33% in 2023.
  • Year by year, Other Accumulated Expenses stood at $35000.0 in 2021, then tumbled by 60.0% to $14000.0 in 2022, then soared by 71.43% to $24000.0 in 2023, then soared by 283.33% to $92000.0 in 2024.
  • Business Quant data shows Other Accumulated Expenses for SLDB at $92000.0 in Q1 2024, $24000.0 in Q4 2023, and $162000.0 in Q3 2023.